750 related articles for article (PubMed ID: 7040100)
1. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
3. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
[TBL] [Abstract][Full Text] [Related]
4. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
Reves R; Heilig CM; Tapy JM; Bozeman L; Kyle RP; Hamilton CD; Bock N; Narita M; Wing D; Hershfield E; Goldberg SV;
Int J Tuberc Lung Dis; 2014 May; 18(5):571-80. PubMed ID: 24903795
[TBL] [Abstract][Full Text] [Related]
5. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
6. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Ahn HC; Lee YC
Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
[TBL] [Abstract][Full Text] [Related]
7. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
Zierski M
Scand J Respir Dis Suppl; 1978; 102():48-52. PubMed ID: 278215
[No Abstract] [Full Text] [Related]
8. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
[TBL] [Abstract][Full Text] [Related]
9. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Dubra F
Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
[No Abstract] [Full Text] [Related]
10. [Intermittent chemotherapy from the beginning or only after a period of daily administration? Quantitative bacteriological study at the initial phase of chemotherapy with INH + RMP + EMB in daily or intermittent administration].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(4):193-205. PubMed ID: 204971
[TBL] [Abstract][Full Text] [Related]
11. [Effectivity of intermittent RMP/EMB treatment in patients with chronic pulmonary tuberculosis (author's transl)].
Frenzel I; Neumeyer D
Z Erkr Atmungsorgane; 1976 Aug; 146(2):145-52. PubMed ID: 1020361
[TBL] [Abstract][Full Text] [Related]
12. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Long MW; Snider DE; Farer LS
Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S
Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
[No Abstract] [Full Text] [Related]
14. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
[No Abstract] [Full Text] [Related]
15. [Chemotherapy of tuberculosis--compliance, side effects and incidence of recurrence].
Brändli O; Häcki MA; Scheel A; Stiefel M
Schweiz Med Wochenschr; 1983 Jan; 113(3):92-6. PubMed ID: 6828844
[TBL] [Abstract][Full Text] [Related]
16. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
Konno K; Oizumi K; Yamada S; Ogata K; Sato M
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
[No Abstract] [Full Text] [Related]
17. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
[No Abstract] [Full Text] [Related]
18. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
Toyota E; Suzuki T; Tagawa K; Takahara M; Ito M; Arai T; Kabe J; Baba H
Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317
[TBL] [Abstract][Full Text] [Related]
19. Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
Gonzalez Montaner LJ; Leston JM; Cetrangolo A; Szemzo J; Calvete C; Dambrosi A; Mosca C
Bull Int Union Tuberc; 1976; 51(1):87-9. PubMed ID: 1030316
[No Abstract] [Full Text] [Related]
20. [Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
Szymański A; Walecki J; Czaplińska-Jóźwiak E; Kuczborska Z; Gaik A; Bilczak Z; Swiatnicka I; Swica T; Zdawski T
Pneumonol Pol; 1980 Nov; 48(11):669-74. PubMed ID: 7255207
[No Abstract] [Full Text] [Related]
[Next] [New Search]